Clin2
NCT07767422Possibly a fitNot yet recruiting

Doxycycline for anal lymphogranuloma venereum infection

Lymphogranuloma Venereumno Anorectal SymptomsDoxycycline

Part of Infections clinical trials.

This study tests whether a 7-day course of the antibiotic doxycycline can effectively treat an anal infection called lymphogranuloma venereum (LGV) in people who have no symptoms. If you have already started doxycycline for this infection, this study may help confirm if the short course is enough.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
120 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • Be 18 years or older and born male
  • Have a positive anal test for lymphogranuloma venereum (LGV)
  • Have already taken doxycycline for at least 2 days (400 mg total) but not more than 7 days at 200 mg per day
  • Have no symptoms in the anus or rectum (like pain, discharge, or bleeding)
  • Be available for follow-up visits over about 4 weeks

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06778083Recruiting
Antibiotic to prevent STIs and its effect on resistance

This study looks at taking doxycycline to prevent sexually transmitted infections (STIs) in men who have sex with men. It focuses on how this approach might affect the body's resistance to antibiotics.

London
NCT06738407Recruiting· Phase 4
Doxycycline to prevent STIs in high-risk people

This study tests whether taking a daily antibiotic (doxycycline) can prevent sexually transmitted infections in people at high risk. If you've had an STI recently and sometimes have sex without condoms, you might be able to join.

Los Angeles, California
NCT07215325Recruiting· Phase 4
Can doxycycline prevent STIs in men?

This trial tests if taking doxycycline after sex can lower the risk of getting sexually transmitted infections (STIs) in men who have sex with men and are at higher risk.

Atlanta, Georgia
NCT07397403Recruiting· Phase 4
Doxycycline to prevent STIs in men who have sex with men

This trial tests whether taking a single dose of doxycycline after sex can prevent common sexually transmitted infections (STIs) like gonorrhea, chlamydia, and syphilis in men who have sex with men (MSM) in Bangkok.

Sathorn, Bangkok
NCT04762134Recruiting
Doxycycline to prevent future bacterial STIs in high-risk men

This trial tests whether taking doxycycline can lower the chance of getting bacterial sexually transmitted infections like syphilis, gonorrhea, and chlamydia. It is aimed at men who have had these infections recently and expect to keep having multiple male partners.

Calgary, Alberta
NCT07704957Not yet recruiting· Phase 4
Preventing bacterial STIs in women with post-sex doxycycline

This study tests whether taking an antibiotic called doxycycline after sex can prevent bacterial STIs (like chlamydia and gonorrhea) in women. You would take the pill within 72 hours after sex and track it with a smartphone app, aiming to reduce your risk of getting an STI.

Hear when a new Lymphogranuloma Venereum trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.